The report Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1,
2018 gives an overview of the global
clinical trials landscape and top-level data related to clinical trials by
Region, Country (G7 and E7), Trial Status, trial Phase, Sponsor type and End
point status. The report reviews top companies involved and enlists all trials
(Trial title, Phase and Status) pertaining to the company and all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for
their non-accomplishments. It provides enrolment trends for the past five years
and the latest news relating to these trials for the past three months. The
companies involved in the clinical trials of prostatic intraepithelial
neoplasia are GTx Inc, SOFAR SpA, Ilmix Group and Advanced
Clinical LLC. The report will enhance the decision- making
capabilities and helps to create an effective counter strategy to gain
competitive advantage and helps in identifying locations to conducting these
trials.
Prostatic Intraepithelial Neoplasia
(PIN) is a condition where some of the prostrate cells have begun to behave
abnormally. These cells are present primarily in two areas- the lining of tiny
sacs known as acini, which gives the prostrate a sponge-like composition and
produce fluid that is added to sperm to create semen; and the lining of ducts that carry this fluid to the main ejaculatory
duct that reaches the penis. PIN is a precancerous condition. Recent studies have shown that only one type
of PIN increases the risk of it developing to a prostate cancer and that the
risk of PIN may not be as serious as first thought.
Clinical
trials are conducted in medical research labs to find better ways to prevent
and treat diseases or diagnose them. They give solutions on the medical
approaches suitable for certain illness to a certain group of people
specifically. These trials help a great deal in making healthcare decisions.
Since they answer scientific questions, these trials are required to be carried
on under strict and scientific standards that protect the interests of the
patients. They are also the final and the most important stage of clinical
research and development. Clinical trials for drugs take place in four phases-
first, they test an experimental drug on a few people and study the effects;
second, they test the drug on more people than in Phase 1 which may extend up
to years; third, they include many other participants to test for safety and
efficacy and study the side effects deeper than in Phase 2; fourth, getting
approval of the usage of drug from the relevant authority.
To
know more, click on the link below:-
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
